Vancouver, British Columbia–(Newsfile Corp. – June 16, 2020) – The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (FSE: YG3) is pleased to share an update on the production and intended rollout and sales of select products in its Urban Juve line and its white label manufacturing operations.
Image 1: Yield Growth Provides Product Manufacturing Update
To view an enhanced version of Image 1, please visit:
https://orders.newsfilecorp.com/files/6377/57941_yg.jpg
Under its Urban Juve subsidiary, which develops and sells the accessibly priced Urban Juve skin care collection made of the highest quality natural ingredients, production is complete on three Face and Body mists with a new atomizer pump – delivering a better dispensing experience on the popular products, now for sale on urbanjuve.com.
Urban Juve’s alcohol-based Ultra-Nourishing Hand Sanitizer Liquid is soon to be shipped to an Amazon Canada warehouse for distribution via Amazon.ca later this month, in addition to being available for sale now at select Pharmasave locations and other retail stores, and on urbanjuve.com. All key ingredients for Urban Juve’s second hand sanitizer product, the Ultra Hydrating Hand Sanitizer Gel, have been secured for manufacturing 100,000 units, and production has been booked to coincide with receipt of packaging in early July. The sanitizer gel has received approval from Health Canada (NPN 80098154) and is listed with the FDA (NDC 75385-0010-1) and is therefore authorized for sale in both Canada and the United States, paving the way to explore distribution via Amazon.com and to urbanjuve.com’s US-based customers.
According to researchandmarkets.com, the market for hand sanitizer across the globe is expected to rise over 600% during 2020, fueled by preventative recommendations by the World Health Organization and driven by the ability of alcohol-based sanitizers to prevent infections and kill bacteria, fungi, and viruses.
“I am immensely proud of how much progress we’ve made on the manufacturing side of our business in the past few months, especially in light of the difficult challenges presented by the COVID-19 crisis,” says Yield Growth Chief Executive Officer Penny White. “We have applied the lessons learned from our early production runs to continuously refine and improve our manufacturing operations. The team has worked hard and pulled together to strive for increased efficiency and cost-effectiveness with every product we produce.”
Finally, Kingdom Brands is close to launching the first of several products within their men’s wellness collection under the Antler brand. Having received all packaging and ingredients, Yield Growth begins production of Antler Deodorant as a white label for Kingdom Brands this month. This long-lasting, all natural, hemp-infused and aluminum-free deodorant is especially well-suited for sensitive skin, and will be for sale both online and in retail stores.
According to a report by Future Market Insights, the global aluminium-free deodorant market is estimated at around US$1.2 billion in 2019, and is expected to grow at a CAGR of nearly 10% from 2019 to 2029.
About The Yield Growth Corp.
The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) is a phytoceutical and consumer packaged goods company that develops and acquires intellectual property and other assets related to plant-based products and therapeutics, and develops, manufactures, markets, sells and distributes plant-based products that improve lives. It has over 200 proprietary wellness formulas at various stages of commercialization, including over 20 products that are now for sale through e-commerce or brick and mortar retail stores. It owns the plant-based skin care brand Urban Juve, which is currently launching several hand sanitizer products, and it owns wellness brands Wright & Well and Jack n Jane. It has 14 patent applications filed in what the Global Wellness Institute reports is a $4.2 trillion-dollar global wellness market. It is developing natural health products, including sunscreen, pain balm, and skin topicals to fight and ward off infectious diseases. Its majority owned subsidiary NeonMind Biosciences Inc. is launching a line of medicinal mushroom products and is developing intellectual property in the emerging area of psychedelic medicine. The Yield Growth management and advisory team has deep experience with global brands including Johnson & Johnson, Procter & Gamble, Skechers and Aritzia.
Investor Relations Contacts:
Penny White, President & CEO
Kevan Matheson, Investor Relations
1-833-514-BOSS 1-833-514-2677
1-833-515-BOSS 1-833-515-2677
The Canadian Securities Exchange has not reviewed, approved or disapproved the contents of this news release.
Cautionary Statement Regarding Forward-Looking Statements
This press release includes forward-looking information and statements (collectively, “forward looking statements”) under applicable Canadian securities legislation. Forward-looking statements are necessarily based upon a number of estimates, forecasts, beliefs and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such risks, uncertainties and factors include, but are not limited to: risks related to the development, testing, licensing, brand development, availability of packaging, intellectual property protection, reduced global commerce and reduced access to raw materials and other supplies do to the spread of the Coronavirus, the potential for not acquiring any rights as a result of the patent application and any products making use of the intellectual property may be ineffective or the company may be unsuccessful in commercializing them; and other approvals will be required before commercial exploitation of the intellectual property can happen. Demand for the company’s products, general business, economic, competitive, political and social uncertainties, delay or failure to receive board or regulatory approvals where applicable, and the state of the capital markets. Yield Growth cautions readers not to place undue reliance on forward-looking statements provided by Yield Growth, as such forward-looking statements are not a guarantee of future results or performance and actual results may differ materially. The forward-looking statements contained in this press release are made as of the date of this press release, and Yield Growth expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/57941